Products for Research Use Only
RegisterLogin

TNF-α (31-45), human

CAT: 0804-HY-P1860-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P1860-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TNF-α (31-45), human is a potent NF-kB pathway activator. TNF-αis a proinflammatory cytokine that induces necrosis or apoptosis. TNF alpha stimulates NF-κB pathway via TNFR2 promotes cancer growth, invasion, and metastasis[1][2][3].
CAS Number
144796-71-4
UNSPSC
12352209
Target
Apoptosis; NF-κB; TNF Receptor
Type
Peptides
Related Pathways
Apoptosis; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tnf-alpha-31-45-human.html
Purity
99.99
Solubility
H2O : 50 mg/mL (ultrasonic)
Smiles
OC(C[C@@H](C(O)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCC(O)=O)NC([C@H](C(C)C)NC(CNC([C@H](CC(N)=O)NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](C)NC([C@H](CC(N)=O)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C69H122N26O22
Molecular Weight
1667.87
References & Citations
[1]Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship (s) . Microsc Res Tech. 2000 Aug 1;50 (3) :184-95.|[2]Xi Rui, et al. RPS3 Promotes the Metastasis and Cisplatin Resistance of Adenoid Cystic Carcinoma. Front Oncol. 2022 Jun 30:12:804439.|[3]Jang DI, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci. 2021 Mar 8;22 (5) :2719.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
NF-κB
Citation 01
Authorea. 2025 Feb 19.|Biocell. 2025 Apr 30.|Biomedicines. 2023 Dec 15;11 (12) :3314.|Cytotechnology. 2021 Oct;73 (5) :727-743.|Eur J Pharmacol. 2023 Dec 15:961:176193.|Front Oncol. 2022 Jun 30;12:804439.|Int Immunopharmacol. 2026 Jan 1;168 (Pt 1) :115856.|J Cell Commun Signal. 2025 Sep 21;19 (3) :e70045.|PLoS One. 2025 Apr 16;20 (4) :e0318311.|Mol Med Rep. 2019 Oct;20 (4) :3565-3572.

Chemical Information

H-Arg-arg-ala-asn-ala-leu-leu-ala-asn-gly-val-glu-leu-arg-asp-OH
CAS Number144796-71-4
PubChem CID71311650
IUPAC Name(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanedioic acid
Molecular FormulaC69H122N26O22
Molecular Weight1667.9
XLogP-10
Topological Polar Surface Area825
Hydrogen Bond Donor Count26
Hydrogen Bond Acceptor Count26
Rotatable Bond Count57
Heavy Atom Count117
Formal Charge0
Complexity3550
SMILES
C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N
InChI
InChI=1S/C69H122N26O22/c1-30(2)23-41(93-64(114)42(24-31(3)4)89-53(103)35(10)85-62(112)45(27-48(72)97)91-55(105)34(9)83-58(108)38(16-13-21-80-68(75)76)86-56(106)37(70)15-12-20-79-67(73)74)61(111)84-36(11)54(104)90-44(26-47(71)96)57(107)82-29-49(98)95-52(33(7)8)65(115)88-40(18-19-50(99)100)60(110)92-43(25-32(5)6)63(113)87-39(17-14-22-81-69(77)78)59(109)94-46(66(116)117)28-51(101)102/h30-46,52H,12-29,70H2,1-11H3,(H2,71,96)(H2,72,97)(H,82,107)(H,83,108)(H,84,111)(H,85,112)(H,86,106)(H,87,113)(H,88,115)(H,89,103)(H,90,104)(H,91,105)(H,92,110)(H,93,114)(H,94,109)(H,95,98)(H,99,100)(H,101,102)(H,116,117)(H4,73,74,79)(H4,75,76,80)(H4,77,78,81)/t34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,52-/m0/s1
InChIKey
HYFATHUJEOQTRM-PJKQPBPGSA-N
Chemical Structure
2D Structure
2D structure of H-Arg-arg-ala-asn-ala-leu-leu-ala-asn-gly-val-glu-leu-arg-asp-OH
CAS: 144796-71-4
CID: 71311650
Formula: C69H122N26O22
MW: 1667.9
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight1667.9
XLogP3-10
Hydrogen Bond Donor Count26
Hydrogen Bond Acceptor Count26
Rotatable Bond Count57
Exact Mass1666.92269963
Monoisotopic Mass1666.92269963
Topological Polar Surface Area825 Ų
Heavy Atom Count117
Formal Charge0
Complexity3550
Isotope Atom Count0
Defined Atom Stereocenter Count14
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-P7217-01IL-31, Human
HY-P1838Proadrenomedullin (45-92), human
HY-P5044α-Synuclein (45-54) (human)
HY-P5041α-Synuclein (34-45) (human)
HY-174518Human TNF mRNA
HY-P4817Human PTH- (1-31)
HY-P1770-01Adrenomedullin (16-31), human
HY-P704391-01IL-31 , Human (HEK293)
HY-179023CDK9-IN-45
HY-161783HDAC6-IN-45

Alternative Products

CatalogName
M41706-01TNF-α (31-45), human
T76026-01TNF-α (31-45), human TFA
MBS8247095-01TNF-Alpha (31-45) (Human)
5-02009TNF - alfa (31 - 45), human
T19584L-01TNF-α (31-45), human acetate
MBS5772054TNF-alpha (31-45), Human
PE-86636-01TNF-Alpha (31-45) Human Peptide
GTR18891132Human TNF alpha (31-45) peptide
A22784-10TNF-α (31-45), human 10mg
A22784-5TNF-α (31-45), human 5mg

Popular Products